In a study published in eClinicalMedicine, researchers at the German Diabetes Center (DDZ) show that automated insulin ...

Researchers have identified a mechanism underlying insulin resistance in adolescents with obesity. The findings, published in ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

New study suggests a psoriasis drug could help slow or prevent Type 1 diabetes. Researchers target TYK2, an ...

A wave of biosimilar approvals, aggressive pricing strategies, and a regulatory sea change are setting the stage for ...

Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

The Danish pharma major, the maker of semaglutide blockbusters Ozempic and Wegovy, is planning to retire a range of insulin formulations available in easy-to-use disposable pen and cartridge forms by ...

R3 Vascular announced today that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting bioresorbable scaffold. Dr. Brian DeRubertis of New York-Presbyterian and ...

Once these marks were altered, the cells not only made insulin but released it in response to glucose, a key hallmark of true beta-cell function. The two drugs used in this study are already ...

insulin levels, and diabetes in young women. Research Design and Methods. Subjects were women (n = 1,940) in the Coronary Artery Risk Development in Young Adults (CARDIA) study, a prospective ...

Gethin Rees, the study’s principal author ... driven by fears that detained persons are ‘drug-seeking’ and looking to ‘top up’ for free.” Stephanie Mulrine, who interviewed people ...

Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and even reduce weight, bringing an oral version of the booming class of drugs ...